Project Grant HT94252510179
Award Date
8/1/25
Completion Date
7/31/29
Dollars Obligated
$1.3M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
San Francisco, CA 94103, USA
Similar Awards
This Project Grant award of $1,008,313.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports advanced biomedical research initiatives at the University of California, San Francisco (UCSF). The funding will enable UCSF to conduct innovative research focused on transforming healthcare for military service members and the broader public, with a particular emphasis on addressing critical medical challenges such as cancer,...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,453,501.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) on June 1, 2024. The grant supports the development of "Targeted Theranostic Nanopolymers for Imaging and Alpha Radiopharmaceutical Therapy of Prostate Cancer" over a period of 3 years through May 31, 2027. As a leading academic medical center, UCSF will leverage its expertise in biomedical...
The Defense Health Agency awarded a $1,453,500.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development program (CFDA 12.420). This 3-year grant, commencing on June 20, 2023, will support UCSF's research to profile and eliminate tumor subclones resistant to radioligand therapy. Through this project, UCSF aims to transform health care for Service Members and the American public by developing innovative and...
This federal Project Grant award, valued at $644,000.00 and issued by the Defense Health Agency, is funding research under the Military Medical Research and Development program (CFDA 12.420) at the University of California, Davis. The goal of the project is to develop a targeted nano-conjugate therapy for bladder cancer. Specifically, the researchers at UC Davis will be working to create an ultra-small DM1 nanoconjugate that can effectively target and treat bladder cancer. The award duration...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,615,000.00 to The Regents of the University of California, San Francisco (UCSF) to conduct research aimed at "DISCOVERING TRANSCRIPTIONAL DRIVERS OF THERAPY-RESISTANT METASTATIC PROSTATE CANCER". The award period runs from May 1, 2024 to April 30, 2027. As a leading academic medical center, UCSF has a strong track record of...
The Defense Health Agency awarded a $656,000.00 Project Grant to The Regents of the University of California, San Francisco (UCSF) under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant will fund research to investigate the role of myeloid cells and other inflammatory components in the progression of Barrett's esophagus to invasive esophageal adenocarcinoma over a 2-year performance period from May 2025 to May 2027. As a leading academic medical...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,228,594.00 to the Regents of the University of California, San Francisco (UCSF) for research on bispecific antibody-drug conjugates against emerging targets in metastatic lethal prostate cancer. The award period is from April 15, 2024 to April 14, 2027. As a leading academic medical center and research institution, UCSF will leverage its...
The University of California, San Francisco (UCSF) has been awarded a $1,202,087 federal Project Grant from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to investigate SSTR1 as a novel biomarker and therapeutic target in advanced prostate cancer. The award, effective July 1, 2024 through June 30, 2028, will enable UCSF researchers to conduct innovative scientific studies to develop new treatments for this challenging disease. As a leading academic...
The University of California, San Francisco (UCSF) has been awarded a $726,750 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). This 3-year federal grant, with a period of performance from June 2024 to June 2027, will support research to elucidate the role of ERα RNA binding activity in breast cancer progression and drug-tolerant persister cells. As a leading academic medical center with extensive experience in federally...
This federal Project Grant award in the amount of $1,041,595.00 was issued by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the general public. Specifically, the grant will fund innovative and impactful research on melanoma conducted by The Regents of the University of California, San Francisco (UCSF), a prominent...